Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Lilly weight-loss drug copycats dealt blow
Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says
The FDA declared the end to shortages of Zepbound and Mounjaro. That could mean new restrictions on pharmacies making custom-made versions.
Lilly's weight-loss drug removed from FDA's shortage list
The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list late on Wednesday, likely piling pressure on firms selling cheaper versions known as compounded drugs.
Lilly weight-loss drug copycats dealt blow as shortage ends
Eli Lilly and Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, threatening to upend the many knockoffs.
17h
on MSN
Here’s Why Eli Lilly and Company (LLY) Surged in Q2
PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded ...
Daily Reporter
14h
Eli Lilly’s weight-loss drugs no longer in shortage, FDA says
Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
US port strike ends
Helene's wake
Sentenced to 9 yrs in prison
Ex-Memphis cops guilty
Accused of sexual assault
California gang busted
5 Chinese nationals charged
OH gov. declares emergency
Golf Hall of Famer dies
US diagnostic errors study
Mortgage rate ticks up
Kirk becomes Category 4
'Rust' gets premiere date
To hire 250,000 workers
Expands online recruitment
Record heat bakes millions
Fruit fly brain mapped
To be closed indefinitely
CA deepfakes law blocked
Dream fire coach Wright
TikTok star charged
Weekly jobless claims rise
Secures $4 billion credit line
US bans 2 Chinese firms
FDA: No longer in shortage
Fifth recall within a year
Student loan plan ruling
Disrupt Russian hackers
Israel strikes central Beirut
Surveys Helene damage
Freed from Gaza captivity
India, US sign minerals pact
Nevada politician guilty
Texas AG sues TikTok
First mpox test approved
Wreck of WWII ship found
Feedback